ESPEROCT is a Kit in the Plasma Derivative category. It is labeled and distributed by Novo Nordisk. The primary component is .
Product ID | 0169-8300_562f94e8-825f-4d7f-b93c-b783ac3a43bc |
NDC | 0169-8300 |
Product Type | Plasma Derivative |
Proprietary Name | ESPEROCT |
Generic Name | Antihemophilic Factor (recombinant), Glycopegylated-exei |
Dosage Form | Kit |
Marketing Start Date | 2019-02-19 |
Marketing Category | BLA / BLA |
Application Number | BLA125671 |
Labeler Name | Novo Nordisk |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-02-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125671 |
Product Type | PLASMA DERIVATIVE |
Marketing Start Date | 2019-11-11 |
Marketing Category | BLA |
Application Number | BLA125671 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2019-02-19 |
NDC | Brand Name | Generic Name |
---|---|---|
0169-8100 | ESPEROCT | antihemophilic factor (recombinant), glycopegylated-exei |
0169-8150 | ESPEROCT | antihemophilic factor (recombinant), glycopegylated-exei |
0169-8200 | ESPEROCT | antihemophilic factor (recombinant), glycopegylated-exei |
0169-8300 | ESPEROCT | antihemophilic factor (recombinant), glycopegylated-exei |
0169-8500 | ESPEROCT | antihemophilic factor (recombinant), glycopegylated-exei |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ESPEROCT 79152765 4697829 Live/Registered |
Novo Nordisk Health Care AG 2014-07-24 |